These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 30714961)

  • 1. Evaluation of Mitochondrial Oxidative Stress in the Brain of a Transgenic Mouse Model of Alzheimer's Disease by in vitro Electron Paramagnetic Resonance Spectroscopy.
    Manabe T; Matsumura A; Yokokawa K; Saito T; Fujikura M; Iwahara N; Matsushita T; Suzuki S; Hisahara S; Kawamata J; Suzuki H; Emoto MC; Fujii HG; Shimohama S
    J Alzheimers Dis; 2019; 67(3):1079-1087. PubMed ID: 30714961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of oxidative stress in the brain of a transgenic mouse model of Alzheimer disease by in vivo electron paramagnetic resonance imaging.
    Matsumura A; Emoto MC; Suzuki S; Iwahara N; Hisahara S; Kawamata J; Suzuki H; Yamauchi A; Sato-Akaba H; Fujii HG; Shimohama S
    Free Radic Biol Med; 2015 Aug; 85():165-73. PubMed ID: 25912481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early detection of redox imbalance in the APPswe/PS1dE9 mouse model of Alzheimer's disease by in vivo electron paramagnetic resonance imaging.
    Emoto MC; Sato-Akaba H; Hamaue N; Kawanishi K; Koshino H; Shimohama S; Fujii HG
    Free Radic Biol Med; 2021 Aug; 172():9-18. PubMed ID: 34058322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Electron Paramagnetic Resonance Signal Correlates with Mitochondrial Dysfunction and Oxidative Stress in an Alzheimer's disease Mouse Brain.
    Fang D; Zhang Z; Li H; Yu Q; Douglas JT; Bratasz A; Kuppusamy P; Yan SS
    J Alzheimers Dis; 2016; 51(2):571-80. PubMed ID: 26890765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early administration of galantamine from preplaque phase suppresses oxidative stress and improves cognitive behavior in APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Saito T; Hisahara S; Iwahara N; Emoto MC; Yokokawa K; Suzuki H; Manabe T; Matsumura A; Suzuki S; Matsushita T; Kawamata J; Sato-Akaba H; Fujii HG; Shimohama S
    Free Radic Biol Med; 2019 Dec; 145():20-32. PubMed ID: 31536772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
    Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
    Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-time imaging of mitochondrial redox reveals increased mitochondrial oxidative stress associated with amyloid β aggregates in vivo in a mouse model of Alzheimer's disease.
    Calvo-Rodriguez M; Kharitonova EK; Snyder AC; Hou SS; Sanchez-Mico MV; Das S; Fan Z; Shirani H; Nilsson KPR; Serrano-Pozo A; Bacskai BJ
    Mol Neurodegener; 2024 Jan; 19(1):6. PubMed ID: 38238819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression.
    Manczak M; Anekonda TS; Henson E; Park BS; Quinn J; Reddy PH
    Hum Mol Genet; 2006 May; 15(9):1437-49. PubMed ID: 16551656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased proteolytic activity of the mitochondrial amyloid-β degrading enzyme, PreP peptidasome, in Alzheimer's disease brain mitochondria.
    Alikhani N; Guo L; Yan S; Du H; Pinho CM; Chen JX; Glaser E; Yan SS
    J Alzheimers Dis; 2011; 27(1):75-87. PubMed ID: 21750375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
    Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
    J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative inactivation of amyloid beta-degrading proteases by cholesterol-enhanced mitochondrial stress.
    de Dios C; Bartolessis I; Roca-Agujetas V; Barbero-Camps E; Mari M; Morales A; Colell A
    Redox Biol; 2019 Sep; 26():101283. PubMed ID: 31376793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative Stress during the Progression of β-Amyloid Pathology in the Neocortex of the Tg2576 Mouse Model of Alzheimer's Disease.
    Porcellotti S; Fanelli F; Fracassi A; Sepe S; Cecconi F; Bernardi C; Cimini A; Cerù MP; Moreno S
    Oxid Med Cell Longev; 2015; 2015():967203. PubMed ID: 25973140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fruitless Wolfberry-Sprout Extract Rescued Cognitive Deficits and Attenuated Neuropathology in Alzheimer's Disease Transgenic Mice.
    Liu SY; Lu S; Yu XL; Yang SG; Liu W; Liu XM; Wang SW; Zhu J; Ji M; Liu DQ; Zhang ZP; Liu RT
    Curr Alzheimer Res; 2018; 15(9):856-868. PubMed ID: 29623840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.
    Drew SC; Barnham KJ
    Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-amyloid mediated nitration of manganese superoxide dismutase: implication for oxidative stress in a APPNLH/NLH X PS-1P264L/P264L double knock-in mouse model of Alzheimer's disease.
    Anantharaman M; Tangpong J; Keller JN; Murphy MP; Markesbery WR; Kiningham KK; St Clair DK
    Am J Pathol; 2006 May; 168(5):1608-18. PubMed ID: 16651627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Drp1 Ameliorates Synaptic Depression, Aβ Deposition, and Cognitive Impairment in an Alzheimer's Disease Model.
    Baek SH; Park SJ; Jeong JI; Kim SH; Han J; Kyung JW; Baik SH; Choi Y; Choi BY; Park JS; Bahn G; Shin JH; Jo DS; Lee JY; Jang CG; Arumugam TV; Kim J; Han JW; Koh JY; Cho DH; Jo DG
    J Neurosci; 2017 May; 37(20):5099-5110. PubMed ID: 28432138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease.
    Yao J; Irwin RW; Zhao L; Nilsen J; Hamilton RT; Brinton RD
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14670-5. PubMed ID: 19667196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Presymptomatic Changes in the Proteome of Mitochondria-Associated Membrane in the APP/PS1 Mouse Model of Alzheimer's Disease.
    Völgyi K; Badics K; Sialana FJ; Gulyássy P; Udvari EB; Kis V; Drahos L; Lubec G; Kékesi KA; Juhász G
    Mol Neurobiol; 2018 Oct; 55(10):7839-7857. PubMed ID: 29468564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation of Mesenchymal Stem Cells Improves Amyloid-β Pathology by Modifying Microglial Function and Suppressing Oxidative Stress.
    Yokokawa K; Iwahara N; Hisahara S; Emoto MC; Saito T; Suzuki H; Manabe T; Matsumura A; Matsushita T; Suzuki S; Kawamata J; Sato-Akaba H; Fujii HG; Shimohama S
    J Alzheimers Dis; 2019; 72(3):867-884. PubMed ID: 31640102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.